HMT Pharma, Inc.
Records under this name other than patents HMT Pharma, Inc. holds now: patents now held by others, patents whose terms have ended, and its applications, pending or abandoned.
Showing 1 to 4 of 4 · Back to HMT Pharma, Inc.
| Patent | Title | Status | Expires | Confidence |
|---|---|---|---|---|
| US 6,291,498 | Method for optimizing pupil size using alpha antagonist Formerly held Term ended Term ended Sep 15, 2020 · From the USPTO record | Term ended | Term ended Sep 15, 2020 | From the USPTO record |
| US 6,420,407 | Ophthalmic formulation which modulates dilation Formerly held Term ended Term ended Sep 15, 2020 · From the USPTO record | Term ended | Term ended Sep 15, 2020 | From the USPTO record |
| US 6,515,006 | Ophthalmic formulation which modulates dilation Formerly held Term ended Term ended Sep 15, 2020 · From the USPTO record | Term ended | Term ended Sep 15, 2020 | From the USPTO record |
| US 6,730,065 | Night vision composition Formerly held Term ended Term ended Sep 15, 2020 · From the USPTO record | Term ended | Term ended Sep 15, 2020 | From the USPTO record |